author-photo

Jennifer Bordeaux

Novartis

45

Papers

911

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 2754: Exploring the interplay between TAM, PD-L1 and immunosuppressive molecules by a novel multiplex immunofluorescence assay in cancer immunotherapy trials

2021 Tumor Biology
Show All
- Source
- Cite
- Save
Citations (0)
Predictive evaluation of quantitative spatial profiling of the tumor microenvironment by multiplex immunofluorescence in recurrent glioblastoma treated with PD-1 inhibitors.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 310: Immunophenotyping tumors by novel multiplex immunofluorescence and AQUA (Automated Quantitative Analyses) algorithms to guide development of immunotherapies

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD5-07: The immune landscape of residual triple-negative breast cancers after neoadjuvant chemotherapy

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
74 Novel approach for profiling immune-tumor cell interactions and mutations in the same tumor section by multiplex immunohistochemistry and NGS in immuno-oncology trials

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
47 Pathologists enhance interpretation of automated multiplex immunohistochemistry assays in cancer immunotherapy trials

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
BIOM-27. PREDICTIVE EVALUATION OF QUANTITATIVE SPATIAL PROFILING OF THE TUMOR MICROENVIRONMENT BY MULTIPLEX IMMUNOFLUORESCENCE IN RECURRENT GLIOBLASTOMA TREATED WITH PD-1 INHIBITORS

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Predictive value of circulating B cells and T cell subsets in melanoma patients treated with neoadjuvant ipilimumab and interferon.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
MEK activation drives glycolysis and supports suppressive myeloid cells in TNBC.

2020 JCI insight
Show All
- Source
- Cite
- Save
Citations (4)